CLOV Clover Health

NASDAQ
$4.17

Clover Health (CLOV) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

Insider signal Moderately bearish Selling ran elevated versus CLOV's own trailing one-year pace, with 63% of sale value under a prearranged plan.
Cluster activity 0 buyers in the last 30 days 0 buyers in the last 90 days 6 sellers in the last 90 days
Insiders buying
0
0 transactions
Insiders selling
6
16 transactions
Purchases
$0
0 shares
Sales
$2.5M
520,746 shares
Net activity
-$2.5M
purchases less sales

How much of that selling was preplanned? 63% planned / 37% discretionary

10b5-1 plan sales $1.5M 5 transactions · 327,268 shares
Discretionary sales $920.7K 11 transactions · 193,478 shares

Largest single sale: $1.4M.

Where they traded

Buy Sell Dot area is proportional to transaction value.

No open-market insider purchase on record.

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
THORNTON JOSEPH CLAY Chief Financial Officer Sell 22,099 $4.97 $109.8K 1,551,783 −1.4% of holding
Soares Karen Chief Legal Officer Sell 10b5-1 19,275 $4.66 $89.8K 1,573,423 −1.2% of holding
Reynoso Jamie L. CEO, Medicare Advantage Sell 10b5-1 4,066 $4.41 $17.9K 2,770,351 −0.1% of holding
Toy Andrew Chief Executive Officer Sell 62,176 $4.68 $291.0K 9,078,334 −0.7% of holding
Wai Conrad CEO, Counterpart Health Sell 23,627 $4.68 $110.6K 1,042,072 −2.2% of holding
Reynoso Jamie L. CEO, Medicare Advantage Sell 18,273 $4.68 $85.5K 2,774,417 −0.7% of holding
Soares Karen Chief Legal Officer Sell 14,673 $4.68 $68.7K 1,592,698 −0.9% of holding
THORNTON JOSEPH CLAY Interim CFO Sell 4,591 $4.68 $21.5K 1,244,935 −0.4% of holding
Reynoso Jamie L. CEO, Medicare Advantage Sell 10b5-1 2,006 $4.63 $9.3K 2,792,690 −0.1% of holding
Reynoso Jamie L. CEO, Medicare Advantage Sell 8,750 $4.42 $38.7K 2,794,696 −0.3% of holding
Reynoso Jamie L. CEO, Medicare Advantage Sell 10b5-1 1,921 $4.56 $8.8K 2,803,446 −0.1% of holding
OLDAKOWSKI JOSEPH FRANK VP OF FINANCE AND CONTROLLER Sell 3,170 $4.64 $14.7K 275,897 −1.1% of holding
Wai Conrad CEO, Counterpart Health Sell 10b5-1 300,000 $4.72 $1.4M 1,170,056 −20.4% of holding
Reynoso Jamie L. CEO, Medicare Advantage Sell 9,273 $4.78 $44.3K 2,805,367 −0.3% of holding
Soares Karen Chief Legal Officer Sell 6,846 $4.78 $32.7K 1,607,371 −0.4% of holding
OLDAKOWSKI JOSEPH FRANK VP OF FINANCE AND CONTROLLER Sell 20,000 $5.16 $103.2K 279,067 −6.7% of holding

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.